Interim results (2-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX

被引：0
|
作者：
Rothschild, C. [1 ]
Trossaert, M. [2 ]
Claeyssens, S. [3 ]
Lambert, T. [4 ]
Hassoun, A. [5 ]
Volot, F. [6 ]
Dubanchet, A. [7 ]
机构：
[1] Necker AP HP Hosp, Hemophilia Treatment Ctr, Paris, France
[2] Hop Hotel Dieu, Hemophilia Treatment Ctr, Nantes, France
[3] Purpan Hosp, Hemophilia Treatment Ctr, Toulouse, France
[4] Bicetre AP HP Hosp, Hemophilia Treatment Ctr, Le Kremlin Bicetre, France
[5] Simone Veil Hosp, Hemophilia Treatment Ctr, Montmorency Foret, France
[6] Bocage Hosp, Hemophilia Treatment Ctr, Dijon, France
[7] Pfizer, Paris, France
来源：
HAEMOPHILIA | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [31] Long-term safety of α-lipoic acid (ALA) consumption:: A 2-year study
    Cremer, D. R.
    Rabeler, R.
    Roberts, A.
    Lynch, B.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2006, 46 (03) : 193 - 201
  • [32] Efficacy and Safety of Dimethyl Fumarate for the Long-term Treatment of Patients with moderate to severe Psoriasis vulgaris under Practical Conditions: Interim Analysis of the non-interventional Study SKILL at Week 52
    Augustin, M.
    Oji, V
    Kirsch, A.
    Diemert, S.
    Ertner, K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 39 - 40
  • [33] Latest Results from PATRO Children, A Multi-Centre, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment
    Kanumakala, Shankar
    Pfaffle, Roland
    Hoybye, Charlotte
    Kristrom, Berit
    Battelino, Tadej
    Zabransky, Markus
    Zouater, Hichem
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 124 - 124
  • [34] Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies
    Baraliakos, Xenofon
    Deodhar, Atul
    van der Heijde, Desiree
    van den Bosch, Filip
    Magrey, Marina
    Maksymowych, Walter P.
    Tomita, Tetsuya
    Xu, Huji
    Massow, Ute
    Vaux, Tom
    Prajapati, Chetan
    Manente, Myriam
    Marten, Alexander
    Gensler, Lianne S.
    RHEUMATOLOGY, 2025,
  • [35] LATEST RESULTS FROM PATRO CHILDREN, A MULTI-CENTRE, NON-INTERVENTIONAL STUDY OF THE LONG-TERM SAFETY AND EFFICACY OF OMNITROPE® IN CHILDREN REQUIRING GROWTH HORMONE TREATMENT
    Pfaeffle, Roland W.
    Kanumakala, Shankar
    Hoybye, Charlotte
    Kristrom, Berit
    Battelino, Tadej
    Colle, Michel
    Zabransky, Markus
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 485 - 486
  • [36] Evaluation of Long-Term Safety of Latanoprost in Pediatric Populations: Design and Rationale of an Ongoing Non-Interventional Cohort Study
    Xu, Wanning
    Huang, Kui
    Sultan, Marla
    Zhang, Min
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 349 - 349
  • [37] Design and Objectives of the Acorn Study: A Non-Interventional Study Evaluating Long-term Safety in Achondroplasia Patients Treated with Vosoritide
    Pimenta, Jeanne M.
    Cohen, Shelda
    Mukherjee, Swati
    Fettes, Fiona
    Jayaram, Kala
    Lausch, Ekkehart
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 127 - 128
  • [38] A national French noninterventional study to assess the long-term safety and efficacy of reformulated nonacog alfa
    Lambert, Thierry
    Rothschild, Chantal
    Volot, Fabienne
    Borel-Derlon, Annie
    Trossaert, Marc
    Claeyssens-Donadel, Segolene
    Attal, Sepideh
    TRANSFUSION, 2017, 57 (04) : 1066 - 1071
  • [39] Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis
    Barraco, Fiorenza
    Grei, Richard
    Herbrecht, Raoul
    Schmidt, Burkhard
    Reiter, Andreas
    Willenbacher, Wolfgang
    Raymakers, Reinier
    Liersch, Rudiger
    Wroclawska, Monika
    Pack, Robert
    Burock, Karin
    Karumanchi, Divyadeep
    Gisslinger, Heinz
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (05) : 764 - 774
  • [40] ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis
    Specker, C.
    Alberding, A.
    Aringer, M.
    Burmester, G-R
    Flacke, J-P
    Hofmann, M. W.
    Kaestner, P.
    Kellner, H.
    Moosig, F.
    Sieburg, M.
    Tony, H-P
    Fliedner, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (02) : 319 - 328
12345